HM Payson & Co’s Lifestance Health LFST Stock Holding History

HM Payson & Co’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2	Closed	–	–	1045
2022 Q2	$0	Buy	+2	New	+$15	﹤0.01%	1096

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HM Payson & Co's LFST Position: Q3 2022 in Review

HM Payson & Co sold out of Lifestance Health (LFST) in Q3 2022, closing a stake of 2 shares.

HM Payson & Co first reported a position in LFST in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 78 funds tracked by Wall St. Rank hold LFST as of Q3 2022.

HM Payson & Co reported no remaining Lifestance Health position as of Q3 2022 after selling out during the quarter.
HM Payson & Co sold 2 Lifestance Health shares in Q3 2022.
HM Payson & Co first reported a position in Lifestance Health in Q2 2022 and held it in 1 quarter.
HM Payson & Co's Lifestance Health position peaked at $0 in Q2 2022.
78 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2022.

Based on HM Payson & Co's 13F filing for Q3 2022, filed 25 Oct 2022.